The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury.
about
Bradykinin beta-2 receptor antagonists for acute traumatic brain injuryThe far-reaching scope of neuroinflammation after traumatic brain injury.Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury.Blocking of bradykinin receptor B1 protects from focal closed head injury in mice by reducing axonal damage and astroglia activation.Discovery and therapeutic potential of kinin receptor antagonists.Emerging pharmacological agents to improve survival from traumatic brain injury.Role of the kallikrein-kinin system in traumatic brain injury.A State-of-the-Science Overview of Randomized Controlled Trials Evaluating Acute Management of Moderate-to-Severe Traumatic Brain Injury.Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.Impact of extended monitoring-guided intensive care on outcome after severe traumatic brain injury: A prospective multicentre cohort study (PariS-TBI study).The currency, completeness and quality of systematic reviews of acute management of moderate to severe traumatic brain injury: A comprehensive evidence map.Neuroprotection in Traumatic Brain Injury: Mesenchymal Stromal Cells can Potentially Overcome Some Limitations of Previous Clinical Trials
P2860
Q24242504-F768C1BF-E0CB-4B46-9811-7CA81C57ECA8Q30235977-A8058970-52F0-4438-BEAC-9D2FB4CAD1F6Q33552728-E2FBD773-FE53-4D5F-94FE-DB97575C26F8Q36211340-EFDBD92E-3355-482C-84A6-B153B6397457Q38055254-0B3AB4B0-DA94-416D-8687-32B0694BBCC0Q38160884-8C4A9819-F1AA-49AD-A176-21FA0289D44FQ38269009-F11A8814-DF24-49F9-B6DB-426A304CE3B9Q38681722-87D0454E-AC2F-454E-B5AA-D92738D85339Q47720411-8DD000FB-5CD6-49E7-AC9A-C9A74EF644C1Q48106463-25D23B4A-6BB4-47FA-B309-7945402EAE2FQ55426553-04A134F2-6B2F-492D-A334-CD576E1F9FF2Q58566923-2830F511-E6D2-40F5-A979-10247A6B14FD
P2860
The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
The BRAIN TRIAL: a randomised, ...... s with traumatic brain injury.
@en
The BRAIN TRIAL: a randomised, ...... s with traumatic brain injury.
@nl
type
label
The BRAIN TRIAL: a randomised, ...... s with traumatic brain injury.
@en
The BRAIN TRIAL: a randomised, ...... s with traumatic brain injury.
@nl
prefLabel
The BRAIN TRIAL: a randomised, ...... s with traumatic brain injury.
@en
The BRAIN TRIAL: a randomised, ...... s with traumatic brain injury.
@nl
P2093
P2860
P356
P1433
P1476
The BRAIN TRIAL: a randomised, ...... s with traumatic brain injury.
@en
P2093
Bennie Hartzenberg
Cristian Boeriu
Cristina Sampaio
Francisco Murillo-Cabezas
Ian Roberts
Indrek Rätsep
Jorge Mejia Mantilla
Juan Diego Ciro Quintero
Laura Balica
P2860
P2888
P356
10.1186/1745-6215-10-109
P577
2009-12-03T00:00:00Z
P5875
P6179
1028456195